Minocycline for Helicobacter Pylori Rescue Treatment
Key facts
- Who runs it
- Shanghai Jiao Tong University School of Medicine
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 823 people enrolled
- Started
- 1 Mar 2021
- Ended
- 30 Apr 2024
- Type of study
- Observational, 5 groups
- Treatments tested
- BQT
- PBM4M4
- PBM3M3
- PBM2M4
- PBM2M3
- Record updated
- 30 December 2024
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Confirmed H. pylori infection and with previous treatment failure
Who cannot take part
- administration of antibiotics, bismuth, antisecretory drugs, or Chinese herb medicine in the preceding 12 weeks
- history of gastrectomy
- severe systemic diseases or malignancy
- subjects naive to H. pylori treatment,
- pregnant or lactating women
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Current guidelines have recommended classical bismuth-containing quadruple therapy including proton-pump inhibitor, bismuth, tetracycline, metronidazole as the empirical rescue therapy. However, tetracycline is clinically unavailable in China and the high frequency of adverse events of bismuth quadruple therapy often result in poor compliance, which limited the applicability of this recommendation. We previously showed that the efficacy of bismuth-containing quadruple therapy with minocycline and metronidazole was not inferior to classical bismuth quadruple therapy for refractory H. pylori infection, though also accompanied with high occurrence of adverse events.This study aimed to evaluate the efficacy and tolerability of four different regimens with minocycline and metronidazole compared to classical bismuth quadruple therapy for H. pylori rescue treatment in a real-world setting.
The 5 groups in the trial
- BQT
- PBM4M4
- PBM3M3
- PBM2M4
- PBM2M3
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Minocycline-containing Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment: a Real-world Evidence Study
- Publications
- Record updated
- 30 December 2024